您的位置: 首页 > 农业专利 > 详情页

PHARMACEUTICAL COMPOSITION COMPRISING ABIRATERONE ACETATE AND DARULOTAMIDE
专利权人:
NanGenex Nanotechnology Incorporated
发明人:
Andrea UJHELYI,Nikoletta ERDOSI,Betti SZABÓNÉ ORDASI,Tamás JORDÁN,Tamás SOLYMOSI,Hristos GLAVINAS
申请号:
US16637206
公开号:
US20200197416A1
申请日:
2018.08.09
申请国别(地区):
US
年份:
2020
代理人:
摘要:
Disclosed herein are pharmaceutical compositions comprising Abiraterone acetate and Darolutamide, which are useful in the treatment of a type of prostate cancer. The pharmaceutical composition possesses increased in-vitro permeability both in fasted and fed state which allows significant dose reduction and the abandoning of the requirement of taking the drugs on an empty stomach. Further disclosed are methods of formulating and manufacturing the pharmaceutical composition, its uses and methods of treatment using the pharmaceutical composition.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充